|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.04 / 0.22|
These health care stocks are scheduled to report their quarterly earnings today.
Poniard Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Poniard Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript
Hovnanian and Blockbuster are among stocks under $5 with the most sell ratings from analysts.
Picoplatin Shows Activity in the Treatment of Small Cell Lung Cancer
Poniard Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session.
Engages Leerink Swann LLC to Explore Strategic Alternatives for the Company; Announces Workforce Restructuring
Several stocks trading near $5 were moving on above-average volume during Monday's session.
- Conference Call Today at 8:30 a.m. Eastern Time -
Medivation's (MDVN) Alzheimer's drug, Dimebon, failed an important drug trial. Hard lessons were learned, as explained in this bonus Mailbag.
Ronald A. Martell Named Chief Executive Officer
Drug maker may try to raise money as approvals of its kidney cancer drug stall out.
Several stocks trading near $5 were poised to move on above-average volume during Monday's session.
Can Poniard attract a partner for a chemo drug that causes less nerve toxicity but may not help patients live longer?